EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroprotective Effects of Vesatolimod in EAE: Modulating Immune Balance and Microglial Polarization

Xueyu Chen, Jian Zhang, Shuhua Mu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xueyu Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Microglia, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Program, Shenzhen Medical Research Fund, Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic autoimmune disease characterized by sustained neuroinflammation and demyelination within the central nervous system (CNS). Vesatolimod (VES), a selective Toll-like receptor 7 (TLR7) agonist, has demonstrated both antiviral and immunomodulatory properties; however, its potential therapeutic value in neuroinflammatory contexts remains poorly understood. In this study, we evaluated the efficacy of VES in the experimental autoimmune encephalomyelitis (EAE) model of MS and elucidated its mechanisms of action. EAE was induced in mice by immunization with myelin oligodendrocyte glycoprotein (MOG35–55). The therapeutic effects of VES were assessed through clinical scoring, body weight monitoring, histopathology, flow cytometry, quantitative proteomics, and Western blot analysis. Additionally, an in vitro model of lipopolysaccharide (LPS)-induced microglial activation was employed to investigate cell-autonomous mechanisms. Results showed that VES administration significantly ameliorated disease severity, reduced weight loss, and enhanced neurological function in EAE mice. Treatment with VES inhibited the differentiation of pro-inflammatory Th1 and Th17 cells while expanding regulatory T cell (Treg) populations. It also preserved blood–brain barrier (BBB) integrity, attenuated demyelination, and modulated microglial activation phenotypes within the CNS. At the molecular level, VES activated the Nrf2/HO-1 antioxidant pathway, thereby enhancing the expression of cytoprotective proteins. Proteomic profiling further revealed the downregulation of inflammation-related proteins, specifically those associated with TNF, IL-17, and NOD-like receptor signaling pathways. Collectively, these findings demonstrate that VES alleviates neuroinflammation in EAE through multimodal mechanisms—including peripheral and central immune regulation, BBB protection, and activation of endogenous antioxidant defenses—supporting its further development as a promising therapeutic candidate for MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalMicrogliaNeuroprotective AgentsAnimalsMiceFemaleTh17 CellsMice, Inbred C57BLMultiple SclerosisBlood-Brain BarrierNF-E2-Related Factor 2T-Lymphocytes, RegulatoryMyelin-Oligodendrocyte GlycoproteinTh1 Cells

Stichwörter der Autor:innen

Nrf2 pathwayVesatolimodexperimental autoimmune encephalomyelitismicroglial polarizationmultiple sclerosisneuroinflammation

Substanzen

Neuroprotective AgentsNF-E2-Related Factor 2Myelin-Oligodendrocyte Glycoprotein

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518055, China.
  • School of Psychology, Shenzhen University, Shenzhen 518060, China.

Förderung

  • Shenzhen Science and Technology Innovation Program
  • Shenzhen Medical Research Fund
  • Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions

Zitieren

APA

Chen, X., Zhang, J., & Mu, S. (2025). Neuroprotective Effects of Vesatolimod in EAE: Modulating Immune Balance and Microglial Polarization. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199297

Vancouver

Chen X, Zhang J, Mu S. Neuroprotective Effects of Vesatolimod in EAE: Modulating Immune Balance and Microglial Polarization. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199297

BibTeX
@article{Chen2025,
  author = {Chen, Xueyu and Zhang, Jian and Mu, Shuhua},
  title = {Neuroprotective Effects of Vesatolimod in EAE: Modulating Immune Balance and Microglial Polarization},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199297}
}
Kostenlos starten →